Effects of CPAP on Blood Pressure and Sympathetic Activity in Patients With Diabetes Mellitus, Chronic Kidney Disease, and Resistant Hypertension

CJC Open - United States
doi 10.1016/j.cjco.2020.03.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Editorial What Should the Optimal Blood Pressure Goal Be in Patients With Diabetes Mellitus or Chronic Kidney Disease?

Archives of Medical Science
Medicine
2012English

Blood Pressure Goals in Patients With Chronic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Nonglycemic Effects of Incretins in Patients With Long-Term Type 1 Diabetes Mellitus and Chronic Kidney Disease

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Survival Benefit of Nephrologic Care in Patients With Diabetes Mellitus and Chronic Kidney Disease

Archives of Internal Medicine
2008English

Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Medical News of North Caucasus
Medicine
2016English

Effect of Alogliptin on Hypertensive Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

Australasian Medical Journal
Medicine
2018English

Long-Term Effects of Aldosterone Blockade in Resistant Hypertension Associated With Chronic Kidney Disease

Journal of Human Hypertension
Internal Medicine
2011English

Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in Chronic Kidney Disease Patients

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2019English

Resistant Hypertension in Diabetes Mellitus

Journal of Endocrinology and Diabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy